218 related articles for article (PubMed ID: 28476025)
21. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
[TBL] [Abstract][Full Text] [Related]
22. PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
Liu H; Al-aidaroos AQ; Wang H; Guo K; Li J; Zhang HF; Zeng Q
BMC Cancer; 2013 Feb; 13():80. PubMed ID: 23418787
[TBL] [Abstract][Full Text] [Related]
23. WAVE1 gene silencing via RNA interference reduces ovarian cancer cell invasion, migration and proliferation.
Zhang J; Zhou S; Tang L; Shen L; Xiao L; Duan Z; Jia L; Cao Y; Mu X
Gynecol Oncol; 2013 Aug; 130(2):354-61. PubMed ID: 23680521
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer.
Zhu L; Zhuang H; Wang H; Tan M; Schwab CL; Deng L; Gao J; Hao Y; Li X; Gao S; Liu J; Lin B
Oncotarget; 2016 Jan; 7(1):729-44. PubMed ID: 26575020
[TBL] [Abstract][Full Text] [Related]
25. SNAI1 overexpression induces stemness and promotes ovarian cancer cell invasion and metastasis.
Lu ZY; Dong R; Li D; Li WB; Xu FQ; Geng Y; Zhang YS
Oncol Rep; 2012 May; 27(5):1587-91. PubMed ID: 22344746
[TBL] [Abstract][Full Text] [Related]
26. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
[TBL] [Abstract][Full Text] [Related]
27. B7-H4 expression promotes tumorigenesis in ovarian cancer.
Cheng L; Jiang J; Gao R; Wei S; Nan F; Li S; Kong B
Int J Gynecol Cancer; 2009 Dec; 19(9):1481-6. PubMed ID: 19955922
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
Li J; Huang H; Li Y; Li L; Hou W; You Z
Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
[TBL] [Abstract][Full Text] [Related]
30. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.
Liu H; Shi H; Fan Q; Sun X
Tumour Biol; 2016 Aug; 37(8):10161-75. PubMed ID: 26831658
[TBL] [Abstract][Full Text] [Related]
31. METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells.
Wu GJ; Zeng GF
BMC Cancer; 2016 Feb; 16():136. PubMed ID: 26906545
[TBL] [Abstract][Full Text] [Related]
32. The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion.
Cui YY; Yan L; Zhou J; Zhao S; Zheng YB; Sun BH; Lv HT; Rong FN; Chang XT
Tumour Biol; 2016 Apr; 37(4):5375-83. PubMed ID: 26563365
[TBL] [Abstract][Full Text] [Related]
33. TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway.
Yang W; Liu L; Li C; Luo N; Chen R; Li L; Yu F; Cheng Z
Cell Death Dis; 2018 Sep; 9(9):908. PubMed ID: 30185771
[TBL] [Abstract][Full Text] [Related]
34. P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway.
Yan L; He Z; Li W; Liu N; Gao S
Cell Cycle; 2021 Sep; 20(18):1875-1889. PubMed ID: 34382920
[TBL] [Abstract][Full Text] [Related]
35. Reduced Klotho expression contributes to poor survival rates in human patients with ovarian cancer, and overexpression of Klotho inhibits the progression of ovarian cancer partly via the inhibition of systemic inflammation in nude mice.
Yan Y; Wang Y; Xiong Y; Lin X; Zhou P; Chen Z
Mol Med Rep; 2017 Apr; 15(4):1777-1785. PubMed ID: 28259911
[TBL] [Abstract][Full Text] [Related]
36. WAVE3-NFκB interplay is essential for the survival and invasion of cancer cells.
Davuluri G; Augoff K; Schiemann WP; Plow EF; Sossey-Alaoui K
PLoS One; 2014; 9(10):e110627. PubMed ID: 25329315
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of KIF26B, Cell Migration and Proliferation of Human Ovarian Cancer Cell Lines In Vitro, and Patient Outcomes from Human Bioinformatic Analysis.
Yang X; Zhang L; Xie L
Med Sci Monit; 2018 Jun; 24():3863-3872. PubMed ID: 29880787
[TBL] [Abstract][Full Text] [Related]
38. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
39. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
[TBL] [Abstract][Full Text] [Related]
40. The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion.
Sossey-Alaoui K; Bialkowska K; Plow EF
J Biol Chem; 2009 Nov; 284(48):33019-29. PubMed ID: 19801681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
